ZP-Triptan: Pivotal trial started

Zosano began a double-blind, placebo-controlled, U.S. pivotal trial to evaluate 1, 1.9 and 3.8 mg ZP-Triptan in about 360 patients. The company is developing ZP-Triptan under section 505(b)(2) of the ...